Genome editing of human embryonic stem cells and induced pluripotent stem cells with zinc finger nucleases for cellular imaging

Circulation Research

Volumn 111, Issue 12, 2012, Pages 1494-1503

  Wang, Yongming ^a   Zhang, Wendy Y ^a   Hu, Shijun ^a   Lan, Feng ^a   Lee, Andrew S ^a   Huber, Bruno ^a   Lisowski, Leszek ^a   Liang, Ping ^a   Huang, Mei ^a   De Almeida, Patricia E ^a   Won, Jong H ^a   Sun, Ning ^a   Robbins, Robert C ^a   Kay, Mark A ^a   Urnov, Fyodor D ^b   Wu, Joseph C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SANGAMO BIOSCIENCES INC   (United States)

Author keywords

homologous recombination; induced pluripotent stem cells; molecular imaging; reporter gene; zinc finger nuclease

Indexed keywords

FIREFLY LUCIFERASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 1 REGULATORY SUBUNIT 12C; RED FLUORESCENT PROTEIN; THYMIDINE KINASE; UNCLASSIFIED DRUG; ZINC FINGER NUCLEASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; FLUORESCENCE IMAGING; GENE EXPRESSION; GENE LOCUS; GENETIC ENGINEERING AND GENE TECHNOLOGY; GENOME EDITING; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN GENOME; LUMINESCENCE; MOLECULAR IMAGING; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DEOXYRIBONUCLEASES; EMBRYONIC STEM CELLS; GENE TARGETING; GENES, REPORTER; GENETIC ENGINEERING; GENOME, HUMAN; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; OPTICAL IMAGING; RNA EDITING; ZINC FINGERS;

EID: 84871539019     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.112.274969     Document Type: Article

References (46)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145-1147. (Pubitemid 28516247)
2. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fbro-blasts by defned factors. Cell. 2007;131:861-872. (Pubitemid 350138099)
3. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917-1920.
4. Burridge PW, Keller G, Gold JD, Wu JC. Production of de novo cardio-myocytes: human pluripotent stem cell differentiation and direct repro-gramming. Cell Stem Cell. 2012;10:16-28.
5. Narsinh K, Narsinh KH, Wu JC. Derivation of human induced plu-ripotent stem cells for cardiovascular disease modeling. Circ Res. 2011;108:1146-1156.
6. Dambrot C, Passier R, Atsma D, Mummery CL. Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models. Biochem J. 2011;434:25-35.
7. Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, Mickunas E, Gay R, Klimanskaya I, Lanza R. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet. 2012;379:713-720.
8. Ghosh Z, Huang M, Hu S, Wilson KD, Dey D, Wu JC. Dissecting the oncogenic and tumorigenic potential of differentiated human induced pluripotent stem cells and human embryonic stem cells. Cancer Res. 2011;71:5030-5039.
9. Cao F, Li Z, Lee A, Liu Z, Chen K, Wang H, Cai W, Chen X, Wu JC. Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation. Cancer Res. 2009;69:2709-2713.
10. Swijnenburg RJ, Schrepfer S, Cao F, Pearl JI, Xie X, Connolly AJ, Robbins RC, Wu JC. In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation. Stem Cells Dev. 2008;17:1023-1029.
11. Barnett BP, Arepally A, Stuber M, Arifn DR, Kraitchman DL, Bulte JW. Synthesis of magnetic resonance-, X-ray-and ultrasound-visible algi-nate microcapsules for immunoisolation and noninvasive imaging of cellular therapeutics. Nat Protoc. 2011;6:1142-1151.
12. Ponomarev V. Nuclear imaging of cancer cell therapies. J Nucl Med. 2009;50:1013-1016.
13. Chen IY, Wu JC. Cardiovascular molecular imaging: focus on clinical translation. Circulation. 2011;123:425-443.
14. Nguyen PK, Lan F, Wang Y, Wu JC. Imaging: guiding the clinical translation of cardiac stem cell therapy. Circ Res. 2011;109:962-979.
15. Swijnenburg RJ, Schrepfer S, Govaert JA, Cao F, Ransohoff K, Sheikh AY, Haddad M, Connolly AJ, Davis MM, Robbins RC, Wu JC. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc Natl Acad Sci USA. 2008;105:12991-12996.
16. Lee AS, Wu JC. Imaging of embryonic stem cell migration in vivo. Methods Mol Biol. 2011;750:101-114.
17. Sun N, Lee A, Wu JC. Long term non-invasive imaging of embryonic stem cells using reporter genes. Nat Protoc. 2009;4:1192-1201.
18. Krishnan M, Park JM, Cao F, Wang D, Paulmurugan R, Tseng JR, Gonzalgo ML, Gambhir SS, Wu JC. Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging. FASEB J. 2006;20:106-108. (Pubitemid 43100482)
19. Kita-Matsuo H, Barcova M, Prigozhina N, et al. Lentiviral vectors and protocols for creation of stable hESC lines for fuorescent tracking and drug resistance selection of cardiomyocytes. PLoS ONE. 2009;4:e5046.
20. Stein S, Ott MG, Schultze-Strasser S, et al. Genomic instability and my-elodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med. 2010;16:198-204.
21. Ott MG, Schmidt M, Schwarzwaelder K, Stein S, Siler U, Koehl U, Glimm H, Kühlcke K, Schilz A, Kunkel H, et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by in-sertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med. 2006;12:401-409.
22. DeKelver RC, Choi VM, Moehle EA, et al. Functional genomics, pro-teomics, and regulatory DNA analysis in isogenic settings using zinc fnger nuclease-driven transgenesis into a safe harbor locus in the human genome. Genome Res. 2010;20:1133-1142.
23. de Souza N. Primer: genome editing with engineered nucleases. Nat Methods. 2012;9:27.
24. Urnov FD, Miller JC, Lee YL, Beausejour CM, Rock JM, Augustus S, Jamieson AC, Porteus MH, Gregory PD, Holmes MC. Highly effcient endogenous human gene correction using designed zinc-fnger nucle-ases. Nature. 2005;435:646-651. (Pubitemid 40825505)
25. Santiago Y, Chan E, Liu PQ, Orlando S, Zhang L, Urnov FD, Holmes MC, Guschin D, Waite A, Miller JC, Rebar EJ, Gregory PD, Klug A, Collingwood TN. Targeted gene knockout in mammalian cells by using engineered zinc-fnger nucleases. Proc Natl Acad Sci USA. 2008;105:5809-5814. (Pubitemid 351758454)
26. Moehle EA, Moehle EA, Rock JM, et al. Targeted gene addition into a specifed location in the human genome using designed zinc fnger nucleases. Proc Natl Acad Sci USA. 2007;104:3055-3060. (Pubitemid 46364112)
27. Carroll D. Genome engineering with zinc-fnger nucleases. Genetics. 2011;188:773-782.
28. Zambrowicz BP, Imamoto A, Fiering S, Herzenberg LA, Kerr WG, Soriano P. Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc Natl Acad Sci USA. 1997;94:3789-3794. (Pubitemid 27180451)
29. Hockemeyer D, Soldner F, Beard C, et al. Effcient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-fnger nucleases. Nat Biotechnol. 2009;27:851-857.
30. Hockemeyer D, Wang H, Kiani S, et al. Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol. 2011;29:731-734.
31. Smith JR, Maguire S, Davis LA, Alexander M, Yang F, Chandran S, Ffrench-Constant C, Pedersen RA. Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration. Stem Cells. 2008;26:496-504. (Pubitemid 351413610)
32. Lombardo A, Cesana D, Genovese P, et al. Site-specifc integration and tailoring of cassette design for sustainable gene transfer. Nat Methods. 2011;8:861-869.
33. Wilson KD, Sun N, Huang M, Zhang WY, Lee AS, Li Z, Wang SX, Wu JC. Effects of ionizing radiation on self-renewal and pluripotency of human embryonic stem cells. Cancer Res. 2010;70:5539-5548.
34. Ray P, Tsien R, Gambhir SS. Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects. Cancer Res. 2007;67:3085-3093. (Pubitemid 46724845)
35. Lafamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol. 2007;25:1015-1024. (Pubitemid 47517637)
36. Li Z, Wilson KD, Smith B, Kraft DL, Jia F, Huang M, Xie X, Robbins RC, Gambhir SS, Weissman IL, Wu JC. Functional and transcrip-tional characterization of human embryonic stem cell-derived en-dothelial cells for treatment of myocardial infarction. PLoS ONE. 2009;4:e8443.
37. Jia F, Wilson KD, Sun N, Gupta DM, Huang M, Li Z, Panetta NJ, Chen ZY, Robbins RC, Kay MA, Longaker MT, Wu JC. A nonviral minicircle vector for deriving human iPS cells. Nat Methods. 2010;7:197-199.
38. Cao F, Wagner RA, Wilson KD, Xie X, Fu JD, Drukker M, Lee A, Li RA, Gambhir SS, Weissman IL, Robbins RC, Wu JC. Transcriptional and functional profling of human embryonic stem cell-derived cardio-myocytes. PLoS ONE. 2008;3:e3474.
39. Li Z, Wu JC, Sheikh AY, Kraft D, Cao F, Xie X, Patel M, Gambhir SS, Robbins RC, Cooke JP, Wu JC. Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation. 2007;116:I46-I54. (Pubitemid 47480769)
40. He JQ, Ma Y, Lee Y, Thomson JA, Kamp TJ. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res. 2003;93:32-39. (Pubitemid 36859038)
41. Itzhaki I, Maizels L, Huber I, Zwi-Dantsis L, Caspi O, Winterstern A, Feldman O, Gepstein A, Arbel G, Hammerman H, Boulos M, Gepstein L. Modelling the long QT syndrome with induced pluripotent stem cells. Nature. 2011;471:225-229.
42. Lombardo A, Genovese P, Beausejour CM, Colleoni S, Lee YL, Kim KA, Ando D, Urnov FD, Galli C, Gregory PD, Holmes MC, Naldini L. Gene editing in human stem cells using zinc fnger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol. 2007;25:1298-1306. (Pubitemid 350076515)
43. Zou J, Sweeney CL, Chou BK, Choi U, Pan J, Wang H, Dowey SN, Cheng L, Malech HL. Oxidase-defcient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc fnger nuclease-mediated safe harbor targeting. Blood. 2011;117:5561-5572.
44. Ellis J. Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum Gene Ther. 2005;16:1241-1246. (Pubitemid 41611651)
45. Ramachandra CJ, Shahbazi M, Kwang TW, Choudhury Y, Bak XY, Yang J, Wang S. Effcient recombinase-mediated cassette exchange at the AAVS1 locus in human embryonic stem cells using baculoviral vectors. Nucleic Acids Res. 2011;39:e107.
46. Cao F, Lin S, Xie X, Ray P, Patel M, Zhang X, Drukker M, Dylla SJ, Connolly AJ, Chen X, Weissman IL, Gambhir SS, Wu JC. In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation. 2006;113:1005-1014. (Pubitemid 43879476)